Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
IM HealthScience® (IMH) today announced that the Functional Dyspepsia Safety Update at 36 months (FDSU36) poster is now available for review at the...
IM HealthScience® (IMH), along with its sister company, Physician's Seal® (PS), have been acquired by Nestlé Health Science. The acquisition was...
IM HealthScience®, innovators of medical foods and dietary supplements, today announced the results of a high-quality, nationwide survey conducted...
IM HealthScience® (IMH) today announced that Irritable Bowel Safety Update at 36 months (IBSSU36) has been accepted for a poster presentation at...
IM HealthScience® (IMH®), innovators of medical foods and dietary supplements, today announced favorable results from a real-world, 12-month,...
IM HealthScience® (IMH®) today announced favorable results from the longest-running post-marketing surveillance study of its type. This study, called ...
IM HealthScience® (IMH), innovators of medical foods and dietary supplements, today announced that a high-quality, nationwide survey, conducted among ...
IM HealthScience®, innovators of medical foods and dietary supplements, today announced that a high-quality, nationwide survey, conducted among a...
IM HealthScience® (IMH) today announced favorable results from the longest-running post-marketing surveillance study of its type. This study called...
IM HealthScience today announced that Clinical and Translational Gastroenterology (CTG), a peer-reviewed medical journal, has published the U.S....
IM HealthScience®, innovators of patented nonprescription medical foods, revealed results of a nationwide survey conducted among gastroenterologists...
IM HealthScience® (IMH) today announced that the 2018 ACG Monograph on Management of Irritable Bowel Syndrome (published in June 2018) reaffirms the...
IM HealthScience® (IMH), innovators of medical foods, today presented favorable, post-marketing safety surveillance data for IBgard®, a novel medical ...
IM HealthScience® (IMH), innovators of medical foods and dietary supplements, today announced final, positive results of a patient-reported...
IM HealthScience®, innovators of medical foods and dietary supplements, today announced a high-quality, nationwide survey conducted among a...
IM HealthScience® (IMH), innovators of medical foods and dietary supplements, today announced a high-quality and replicated nationwide survey...
IM HealthScience® (IMH) today announced favorable results from its Irritable Bowel Syndrome Safety Update at 24 Months (IBSSU-24), a real-world...
IM HealthScience®, innovators of FDgard®, a clinically studied, non-prescription medical food using a novel approach in the dietary management of...
IM HealthScience®, innovators of IBgard®, a clinically studied, non-prescription medical food using a novel approach in the dietary management of...
IM HealthScience® (IMH) today announced complete and final results of FDACT™ (Functional Dyspepsia Adherence and Compliance Trial), a real-world...
IM HealthScience® today announced that Internal Medicine Review, a global, peer-reviewed medical journal, has published the first-ever clinical data...
IM HealthScience® (IMH) today announced favorable results from its Functional Dyspepsia Safety Update at 12 months (FDSU-12), a real-world,...
The more recent scientific understanding of Irritable Bowel Syndrome (IBS) having multiple causes, including reversible, low-grade inflammation,...
Landmark clinical data highlight an advance in the management of Functional Dyspepsia (FD) with FDgard®, the only product available for the dietary...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.